Urology · Manhasset, NY
NPI
1568599447
Since 2007
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
315 E Shore Rd
Manhasset, NY, 11030
Phone (516) 487-5577
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.1M
18,252 services
Medicare patients, 2024
1,044
Average age 75
Drug cost, 2024
$1.7M
5,676 prescriptions
Company payments, 2025
$709
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael Ohebshalom was code 76857 (ultrasound - abdomen and pelvis), 1,375 times for 907 patients. In total Michael Ohebshalom billed 18,252 services in 86 codes, and Medicare paid $1.1M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-12-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 76857 Ultrasound - Abdomen and Pelvis | Office | 1,375 | 907 | $48.04 | $66K |
| 36415 Venipuncture Blood Collection | Office | 1,374 | 734 | $6.77 | $9,304 |
| 51741 Test - Miscellaneous | Office | 1,352 | 785 | $7.10 | $9,597 |
| 81002 Clinical Chemistry | Office | 1,286 | 816 | $3.40 | $4,378 |
| 51784 Neurologic | Office | 1,201 | 775 | $30.13 | $36K |
| 99214 Office E&M - Established | Office | 1,174 | 637 | $114.52 | $134K |
| 99213 Office E&M - Established | Office | 1,076 | 604 | $79.56 | $86K |
| 81003 Clinical Chemistry | Office | 958 | 731 | $2.20 | $2,108 |
| 51729 Other Organ Systems | Office | 647 | 591 | $384.66 | $249K |
| 76872 Ultrasound - Nonspecific | Office | 640 | 598 | $135.84 | $87K |
| 87081 Bacterial Culture | Office | 592 | 504 | $6.50 | $3,848 |
| J3490 Unclassified drugs | Office | 435 | 56 | $134.16 | $58K |
| 55899 Other Organ Systems | Office | 391 | 389 | $260.84 | $102K |
| 51798 Ultrasound - Nonspecific | Office | 366 | 298 | $10.48 | $3,836 |
| 84403 Clinical Chemistry | Office | 366 | 268 | $25.29 | $9,256 |
By year: 2022 $1.1M for 15,757 services; 2023 $1.0M for 15,614 services; 2024 $1.1M for 18,252 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,374 | 734 | $6.77 | $9,304 |
| 81002 Clinical Chemistry | 1,286 | 816 | $3.40 | $4,378 |
| 81003 Clinical Chemistry | 958 | 731 | $2.20 | $2,108 |
| 87081 Bacterial Culture | 592 | 504 | $6.50 | $3,848 |
| 84403 Clinical Chemistry | 366 | 268 | $25.29 | $9,256 |
| 80053 Clinical Chemistry | 302 | 261 | $10.35 | $3,126 |
| 83001 Clinical Chemistry | 291 | 253 | $18.21 | $5,299 |
| 83002 Clinical Chemistry | 291 | 253 | $18.15 | $5,282 |
| 84270 Clinical Chemistry | 291 | 254 | $21.30 | $6,198 |
| 82670 Clinical Chemistry | 291 | 253 | $27.38 | $7,968 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael Ohebshalom prescribed most often to Medicare patients was Tamsulosin Hcl, with 2,003 prescriptions and refills. In total Michael Ohebshalom wrote 5,676 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 2,003 | 5,597 | 697 | $36K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 682 | 1,867 | 273 | $20K |
| Finasteride Generic | 618 | 1,746 | 201 | $8,936 |
| Myrbetriq Mirabegron | 322 | 685 | 92 | $300K |
| Ciprofloxacin Hcl Generic | 218 | 220 | 166 | $791 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 197 | 550 | 74 | $4,040 |
| Cefuroxime Cefuroxime Axetil | 160 | 160 | 124 | $1,894 |
| Lupron Depot Leuprolide Acetate | 152 | 461 | 66 | $893K |
| Gemtesa Vibegron | 138 | 305 | 62 | $142K |
| Nystatin Generic | 81 | 90 | 50 | $1,118 |
| Estradiol Generic | 71 | 155 | 33 | $5,297 |
| Triamcinolone Acetonide Generic | 58 | 69 | 44 | $757 |
| Diazepam Generic | 54 | 54 | 45 | $48.94 |
| Dutasteride Generic | 54 | 156 | 16 | $2,073 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 54 | 54 | 45 | $613 |
Brand drugs: 772 claims; generic drugs: 4,904 claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael Ohebshalom $709 ($709 in general payments such as food, travel and fees) from 10 companies. The largest payer was Sumitomo Pharma America, Inc. with $229.
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. 4506.T | 19 | $229 |
| Teleflex LLC TFX | 2 | $148 |
| Janssen Biotech, Inc. JNJ | 1 | $125 |
| Coloplast Corp | 2 | $45.62 |
| Ferring Pharmaceuticals Inc. | 2 | $44.74 |
| Myriad Genetic Laboratories, Inc. MYGN | 1 | $31.7 |
| CIVCO Medical Instruments | 1 | $28.17 |
| Verity Pharmaceuticals Inc. | 1 | $21.87 |
| Medtronic, Inc. MDT | 1 | $18.58 |
| Accord Healthcare, Inc. | 1 | $16 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.